Literature DB >> 22863193

Optimal unified approach for rare-variant association testing with application to small-sample case-control whole-exome sequencing studies.

Seunggeun Lee1, Mary J Emond, Michael J Bamshad, Kathleen C Barnes, Mark J Rieder, Deborah A Nickerson, David C Christiani, Mark M Wurfel, Xihong Lin.   

Abstract

We propose in this paper a unified approach for testing the association between rare variants and phenotypes in sequencing association studies. This approach maximizes power by adaptively using the data to optimally combine the burden test and the nonburden sequence kernel association test (SKAT). Burden tests are more powerful when most variants in a region are causal and the effects are in the same direction, whereas SKAT is more powerful when a large fraction of the variants in a region are noncausal or the effects of causal variants are in different directions. The proposed unified test maintains the power in both scenarios. We show that the unified test corresponds to the optimal test in an extended family of SKAT tests, which we refer to as SKAT-O. The second goal of this paper is to develop a small-sample adjustment procedure for the proposed methods for the correction of conservative type I error rates of SKAT family tests when the trait of interest is dichotomous and the sample size is small. Both small-sample-adjusted SKAT and the optimal unified test (SKAT-O) are computationally efficient and can easily be applied to genome-wide sequencing association studies. We evaluate the finite sample performance of the proposed methods using extensive simulation studies and illustrate their application using the acute-lung-injury exome-sequencing data of the National Heart, Lung, and Blood Institute Exome Sequencing Project.
Copyright © 2012 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22863193      PMCID: PMC3415556          DOI: 10.1016/j.ajhg.2012.06.007

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  32 in total

1.  SIFT: Predicting amino acid changes that affect protein function.

Authors:  Pauline C Ng; Steven Henikoff
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

2.  Optimal tests for rare variant effects in sequencing association studies.

Authors:  Seunggeun Lee; Michael C Wu; Xihong Lin
Journal:  Biostatistics       Date:  2012-06-14       Impact factor: 5.899

3.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data.

Authors:  Aaron McKenna; Matthew Hanna; Eric Banks; Andrey Sivachenko; Kristian Cibulskis; Andrew Kernytsky; Kiran Garimella; David Altshuler; Stacey Gabriel; Mark Daly; Mark A DePristo
Journal:  Genome Res       Date:  2010-07-19       Impact factor: 9.043

4.  Extending rare-variant testing strategies: analysis of noncoding sequence and imputed genotypes.

Authors:  Matthew Zawistowski; Shyam Gopalakrishnan; Jun Ding; Yun Li; Sara Grimm; Sebastian Zöllner
Journal:  Am J Hum Genet       Date:  2010-11-12       Impact factor: 11.025

5.  Rare-variant association testing for sequencing data with the sequence kernel association test.

Authors:  Michael C Wu; Seunggeun Lee; Tianxi Cai; Yun Li; Michael Boehnke; Xihong Lin
Journal:  Am J Hum Genet       Date:  2011-07-07       Impact factor: 11.025

6.  A general framework for detecting disease associations with rare variants in sequencing studies.

Authors:  Dan-Yu Lin; Zheng-Zheng Tang
Journal:  Am J Hum Genet       Date:  2011-09-01       Impact factor: 11.025

7.  Comparison of statistical tests for disease association with rare variants.

Authors:  Saonli Basu; Wei Pan
Journal:  Genet Epidemiol       Date:  2011-07-18       Impact factor: 2.135

8.  Statistical evaluation of ventilator-free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome.

Authors:  David A Schoenfeld; Gordon R Bernard
Journal:  Crit Care Med       Date:  2002-08       Impact factor: 7.598

Review 9.  Common vs. rare allele hypotheses for complex diseases.

Authors:  Nicholas J Schork; Sarah S Murray; Kelly A Frazer; Eric J Topol
Journal:  Curr Opin Genet Dev       Date:  2009-05-28       Impact factor: 5.578

10.  Exome sequencing of extreme phenotypes identifies DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis.

Authors:  Mary J Emond; Tin Louie; Julia Emerson; Wei Zhao; Rasika A Mathias; Michael R Knowles; Fred A Wright; Mark J Rieder; Holly K Tabor; Deborah A Nickerson; Kathleen C Barnes; Ronald L Gibson; Michael J Bamshad
Journal:  Nat Genet       Date:  2012-07-08       Impact factor: 38.330

View more
  461 in total

1.  Evaluation of a two-step iterative resampling procedure for internal validation of genome-wide association studies.

Authors:  Guolian Kang; Wei Liu; Cheng Cheng; Carmen L Wilson; Geoffrey Neale; Jun J Yang; Kirsten K Ness; Leslie L Robison; Melissa M Hudson; Deo Kumar Srivastava
Journal:  J Hum Genet       Date:  2015-09-17       Impact factor: 3.172

2.  An efficient resampling method for calibrating single and gene-based rare variant association analysis in case-control studies.

Authors:  Seunggeun Lee; Christian Fuchsberger; Sehee Kim; Laura Scott
Journal:  Biostatistics       Date:  2015-09-11       Impact factor: 5.899

3.  Identification of Rare Variants in ATP8B4 as a Risk Factor for Systemic Sclerosis by Whole-Exome Sequencing.

Authors:  Li Gao; Mary J Emond; Tin Louie; Chris Cheadle; Alan E Berger; Nicholas Rafaels; Candelaria Vergara; Yoonhee Kim; Margaret A Taub; Ingo Ruczinski; Stephen C Mathai; Stephen S Rich; Deborah A Nickerson; Laura K Hummers; Michael J Bamshad; Paul M Hassoun; Rasika A Mathias; Kathleen C Barnes
Journal:  Arthritis Rheumatol       Date:  2016-01       Impact factor: 10.995

4.  A general approach for combining diverse rare variant association tests provides improved robustness across a wider range of genetic architectures.

Authors:  Brian Greco; Allison Hainline; Jaron Arbet; Kelsey Grinde; Alejandra Benitez; Nathan Tintle
Journal:  Eur J Hum Genet       Date:  2015-10-28       Impact factor: 4.246

5.  The role of SHANK2 rare variants in schizophrenia susceptibility.

Authors:  J Costas
Journal:  Mol Psychiatry       Date:  2015-08-25       Impact factor: 15.992

6.  Meta-analysis of Complex Diseases at Gene Level with Generalized Functional Linear Models.

Authors:  Ruzong Fan; Yifan Wang; Chi-Yang Chiu; Wei Chen; Haobo Ren; Yun Li; Michael Boehnke; Christopher I Amos; Jason H Moore; Momiao Xiong
Journal:  Genetics       Date:  2015-12-29       Impact factor: 4.562

7.  The effect of phenotypic outliers and non-normality on rare-variant association testing.

Authors:  Paul L Auer; Alex P Reiner; Suzanne M Leal
Journal:  Eur J Hum Genet       Date:  2016-01-06       Impact factor: 4.246

8.  Codon bias among synonymous rare variants is associated with Alzheimer's disease imaging biomarker.

Authors:  Jason E Miller; Manu K Shivakumar; Shannon L Risacher; Andrew J Saykin; Seunggeun Lee; Kwangsik Nho; Dokyoon Kim
Journal:  Pac Symp Biocomput       Date:  2018

9.  Sequencing of the GBA coactivator, Saposin C, in Parkinson disease.

Authors:  Bouchra Ouled Amar Bencheikh; Etienne Leveille; Jennifer A Ruskey; Dan Spiegelman; Christopher Liong; Edward A Fon; Guy A Rouleau; Yves Dauvilliers; Nicolas Dupre; Roy N Alcalay; Ziv Gan-Or
Journal:  Neurobiol Aging       Date:  2018-07-02       Impact factor: 4.673

10.  Genome-wide association study and admixture mapping reveal new loci associated with total IgE levels in Latinos.

Authors:  Maria Pino-Yanes; Christopher R Gignoux; Joshua M Galanter; Albert M Levin; Catarina D Campbell; Celeste Eng; Scott Huntsman; Katherine K Nishimura; Pierre-Antoine Gourraud; Kiana Mohajeri; Brian J O'Roak; Donglei Hu; Rasika A Mathias; Elizabeth A Nguyen; Lindsey A Roth; Badri Padhukasahasram; Andres Moreno-Estrada; Karla Sandoval; Cheryl A Winkler; Fred Lurmann; Adam Davis; Harold J Farber; Kelley Meade; Pedro C Avila; Denise Serebrisky; Rocio Chapela; Jean G Ford; Michael A Lenoir; Shannon M Thyne; Emerita Brigino-Buenaventura; Luisa N Borrell; William Rodriguez-Cintron; Saunak Sen; Rajesh Kumar; Jose R Rodriguez-Santana; Carlos D Bustamante; Fernando D Martinez; Benjamin A Raby; Scott T Weiss; Dan L Nicolae; Carole Ober; Deborah A Meyers; Eugene R Bleecker; Steven J Mack; Ryan D Hernandez; Evan E Eichler; Kathleen C Barnes; L Keoki Williams; Dara G Torgerson; Esteban G Burchard
Journal:  J Allergy Clin Immunol       Date:  2014-12-06       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.